Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.05

-0.6%

Dec 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4847)	10/22/2001 11:56:20 PM
From: Miljenko Zuanic	Read Replies (1) of 52153

<<So maybe a Herceptin/C225 combo would be good.>> Anti-Her2/EGF combo is dream of the many bios. I still remember that NDA did have some complain about C225 origin. Did not look at issue for some time. One good reason that NDA license OSIP Tarceva is this combination. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next